Drugs / Lipiodol UltraFluid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05608590 | Aug 2019 → Dec 2025 | female infertility | Amsterdam UMC, location VUmc | Unknown | No outcome recorded |
| Phase 4 | NCT02625389 | Nov 2017 → May 2021 | angiosarcoma, congenital hemangioma, hemangioendothelioma, vascular malformation | Guerbet | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 7
| Date | Issuer | Release |
|---|---|---|
| 2026-04-24 | Guerbet | Regulatory Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) guerbet.com ↗
Guerbet, a global leader in medical imaging, announces a positive outcome from a worksharing procedure, involving several EU member states, for a new Lipiodol ® indication in interventional radiology. |
| 2020-12-08 | Guerbet | Regulatory UK approves Lipiodol ® Ultra Fluid for hysterosalpingography in women undergoing infertility workup guerbet.com ↗
Guerbet (GBT) has been granted approval for an indication extension in the United Kingdom, where Lipiodol ® Ultra Fluid is the only oil-based contrast medium indicated for hysterosalpingography (HSG) in women undergoing infertility workup. |
| 2020-07-29 | Guerbet | Regulatory Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) for tubal flushing in women undergoing infertility workup in Denmark guerbet.com ↗
Guerbet (GBT) announced today that the Danish Medicines Agency has granted approval for an extension of the indication of Lipiodol ® Ultra Fluid in Denmark, where it is now indicated for hysterosalpingography (HSG) for tubal flushing in women undergoing infertility workup. |
| 2020-03-23 | Guerbet | Regulatory Hungary and the Netherlands approve Lipiodol ® Ultra Fluid for hysterosalpingography in women undergoing infertility workup guerbet.com ↗
Guerbet (GBT), a global leader in medical imaging, has announced that it has received indication approval in Hungary and the Netherlands where Lipiodol ® Ultra Fluid is now indicated for hysterosalpingography (HSG) in women undergoing infertility workup. |
| 2020-02-12 | Guerbet | Regulatory Lipiodol ® Ultra Fluid indicated for hysterosalpingography (HSG) in women undergoing infertility workup in Ireland guerbet.com ↗
Guerbet (GBT) has announced that it has been granted approval for an indication extension in Ireland, where Lipiodol ® Ultra Fluid is now indicated for hysterosalpingography (HSG) in women undergoing infertility workup. |
| 2018-09-11 | Guerbet | Regulatory New indication approved for Guerbet’s Lipiodol® Ultra Fluid guerbet.com ↗
Lipiodol® Ultra Fluid now approved for conventional trans-arterial chemoembolization of intermediate-stage hepatocellular carcinoma |
| 2017-05-18 | Guerbet | Results H2Oil Trial using Lipiodol® UF for hysterosalpingography published in the New England Journal of Medicine guerbet.com ↗
Guerbet announced that a clinical study, published today in the New England Journal of Medicine and presented at the 13 th World Congress on Endometriosis in Vancouver, Canada, shows interesting clinical data about hysterosalpingography examination with Lipiodol ® Ultra-Fluide. |
All press releases naming this drug 7 releases
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipiodol Ultra Fluid | “The study is designed to investigate the safety of Lipiodol® Ultra Fluid in association with surgical glues used according to each site medical practice of vascular embolization.” NCT02625389 ↗ |
| Known as | Lipiodol | “The investigational product is an oil-based contrast medium, Lipiodol® (Guerbet).” NCT05608590 ↗ |
| Route | Other | “Lipiodol Ultra Fluid and surgical glue mixture administered via selective arterial catheterization.” NCT02625389 ↗ |